Fractionated chemotherapy — Granisetron or conventional antiemetics?
- 1 January 1992
- journal article
- clinical trial
- Published by Elsevier in European Journal Of Cancer
- Vol. 28, S21-S28
- https://doi.org/10.1016/0959-8049(92)90632-c
Abstract
No abstract availableKeywords
This publication has 15 references indexed in Scilit:
- A single-blind study of the efficacy and safety of intravenous granisetron compared with alizapride plus dexamethasone in the prophylaxis and control of emesis in patients receiving 5-day cytostatic therapyEuropean Journal Of Cancer, 1992
- The concept of selectivity in 5-HT receptor researchEuropean Journal of Pharmacology: Molecular Pharmacology, 1990
- New antiemetic drugsCanadian Journal of Physiology and Pharmacology, 1990
- Neuropharmacology of emesis induced by anti-cancer therapyTrends in Pharmacological Sciences, 1988
- A Prospective Randomized Double-Blind Crossover Study Comparing the Antiemetic Activity of Alizapride and Metoclopramide in Patients Receiving Cisplatin ChemotherapyCancer Investigation, 1988
- Optimum Management of Nausea and Vomiting in Cancer ChemotherapyDrugs, 1987
- PHARMACOKINETICS OF HIGH-DOSE IV ALIZAPRIDE IN PREVENTION OF CISPLATIN-INDUCED EMESISFundamental & Clinical Pharmacology, 1987
- Extrapyramidal Reactions with High-Dose MetoclopramideNew England Journal of Medicine, 1983
- On the receiving end—patient perception of the side-effects of cancer chemotherapyEuropean Journal of Cancer and Clinical Oncology, 1983
- Antiemetic Efficacy of High-Dose Metoclopramide: Randomized Trials with Placebo and Prochlorperazine in Patients with Chemotherapy-Induced Nausea and VomitingNew England Journal of Medicine, 1981